Literature DB >> 28847908

Introduction to Patient-Reported Outcomes Perspectives Series.

Manjula Kurella Tamura1.   

Abstract

Entities:  

Keywords:  Humans; Outcome Assessment (Health Care); Patient Reported Outcome Measures; patient reported outcomes

Mesh：

Year:  2017        PMID： 28847908      PMCID： PMC5672976          DOI： 10.2215/CJN.07700717

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  Using Patient-Reported Measures in Dialysis Clinics.

Authors:  John D Peipert; Ron D Hays
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-14       Impact factor: 8.237

2.  Considerations and Challenges in Selecting Patient-Reported Outcome Measures for Clinical Trials in Nephrology.

Authors:  Angela Ju; Allison Tong
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-28       Impact factor: 8.237

3.  Time to Rethink Our Approach to Patient-Reported Outcome Measures for ESRD.

Authors:  Fredric O Finkelstein; Susan H Finkelstein
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-28       Impact factor: 8.237

Review 4.  What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials.

Authors:  Grigorios Kotronoulas; Nora Kearney; Roma Maguire; Alison Harrow; David Di Domenico; Suzanne Croy; Stephen MacGillivray
Journal:  J Clin Oncol       Date:  2014-04-07       Impact factor: 44.544

5.  Renal provider recognition of symptoms in patients on maintenance hemodialysis.

Authors:  Steven D Weisbord; Linda F Fried; Maria K Mor; Abby L Resnick; Mark L Unruh; Paul M Palevsky; David J Levenson; Stephen H Cooksey; Michael J Fine; Paul L Kimmel; Robert M Arnold
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-08       Impact factor: 8.237

6.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.